Abstract LB-068: From intracellular antibody fragments to small molecule inhibitors of mutant KRAS
Autors principals: | Quevedo, C, Cruz, A, Tulmin, H, Bataille, C, Tanaka, T, Petch, D, Russell, A, Phillips, S, Rabbitts, T |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
American Association for Cancer Research
2017
|
Ítems similars
-
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
per: Quevedo, C, et al.
Publicat: (2018) -
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
per: Camilo E. Quevedo, et al.
Publicat: (2018-08-01) -
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
per: Bery, N, et al.
Publicat: (2018) -
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
per: Nicolas Bery, et al.
Publicat: (2020-06-01) -
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
per: Ke Xu, et al.
Publicat: (2019-04-01)